Document is current

Article History

Received: 8 May 2024

Accepted: 8 June 2026

First Online: 26 June 2026

Declarations

:

: This study was approved by the ethics committees at the two institutions in China which were the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (XHEC-C-2020–053-1, and the Ethics Committee of Shanghai Public Health Clinical Center (2020-E151-01, respectively and conducted in compliance with the Declaration of Helsinki and the International Conference on Harmonization Guidelines for Good Clinical Practice. This study was also approved by the Human Genetic Resource Administrative Committee of the Ministry of Science and Technology of China according to the applicable regulation before the study was initiated. Prior to enrollment, parent(s)/legally authorized representative provided written informed consent. This trial was registered on ClinicalTrials.gov (NCT04880083).

: TMS, SKD, KV, JPG, ND, XW, LR, QL, JD, JB, EK, and JR are employees of Société des Produits Nestlé S.A., the sponsors of this trial. ATV was an employee of Société des Produits Nestlé S.A. at the time the study was conducted. KW, QZ are employees of Beijing Genomics Institute, with whom Nestlé had a service agreement. YW, ML and WC received a grant from Nestlé to conduct the study. The investigational products were provided by Wyeth Nutritional (China) Co., Limited.

: Not applicable as the manuscript does not contain data from any individual person.